Detection of cytokine mRNA in human, articular cartilage from patients with rheumatoid arthritis and osteoarthritis by reverse transcriptase- polymerase chain reaction

Scandinavian Journal of Rheumatology

Volumn 27, Issue 1, 1998, Pages 61-67

  Leistad, L ^a   Ostensen M ^b   Faxvaag, A ^b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cartilage; mRNA expression of cytokines; Osteoarthritis; Rheumatoid arthritis; RT PCR

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 7; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; ARTICULAR CARTILAGE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CARTILAGE, ARTICULAR; CYTOKINES; DNA PRIMERS; ELECTROPHORESIS, AGAR GEL; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; RNA-DIRECTED DNA POLYMERASE;

EID: 0031906090     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/030097498441191     Document Type: Article

References (40)

1. Miossec P, Chomarat P, Dechanet J. Bypassing the antigen to control the rheumatoid arthritis. Immunol Today 1996;17:170-3.
2. Westacott CI, Sharif M. Cytokines in Osteoarthritis:Mediators or markers of joint destruction? Semin Arthritis Rheum 1996;25:254-72.
3. Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldmann M. Immunoregulatory role of interleukin-10 in rheumatoid arthritis. J Exp Med 1994;179:1517-27.
4. Deleuran B, Iversen L, Kristensen M, Field M, Kragballe K, Thestrup-Pedersen K, et al. Interleukin-8 secretion and 15 lipoxygenase activity in rheumatoid arthritis: in vitro antiinflammatory effects by interleukin-4 and interleukln-10, but not by interleukin-1 receptor antagonist protein. Br J Rheumatol 1994;33:520-5.
5. Recklies AD, Golds EE. Induction of synthesis and release of interleukin-8 from human articular chondrocytes and cartilage explants. Arthritis Rheum 1992;35:1510-9.
6. Cush JJ, Splawski JB, Thomas R, McFarlin JE, SchulzeKoops H, Davis LS, et al. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum 1995;38:96-104.
7. van Roon JAG, van Roy JLAM, Gmelig-Meyling FHJ, Lafeber FPJG, Bijlsma JWJ. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum 1996;39:829-35.
8. Seid JM, Rahman S, Graveley R, Bunning RAD, Nordmann R. Wishart W, et al. The effect of interleukin-1 on cytokine gene expression in cultured human articular chondrocytes analyzed by messenger RNA phenotyping. Arthritis Rheum 1993;36:35-43.
9. Wood NC, Symons JA, Dickens E, Duff GW. In situ hybridization of IL-6 in rheumatoid arthritis. Clin Exp Immunol 1992;87:183-9.
10. Tanabe BK, Abe LM, Kimura LH, Reinker KA, Yamaga KM. Cytokine mRNA repertoire of articular chondrocytes from arthritic patients, infants, and neonatal mice. Rheumatol Int 1996;16:67-76.
11. Salmon EV, Serpier H, Nawrocki B, Gillery P, Clavel C, Kalis B, et al. Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis. Arch Dermatol 1996;1.32:802-6.
12. Moller P, Bohm M, Czarnetski BM, Schadendorf D. Interleukin-7. Biology and implications for dermatology. Exp Dermatol 1996;5:129-37.
13. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
14. Kawasaki ES, Clark SS, Coyne MY, Smith SD, Champlin R, Witte ON, et al. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci USA 1988;85:5698-702.
15. Rappolee DA, Mark D, Banda MJ, Werb Z. Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. Science 1988;241:708-12.
16. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
17. Villiger PM, Geng Y, Lotz M. Induction of cytokine expression by leukemia inhibitory factor. J Clin Invest 1993;91:1575-81.
18. Dodds RA, Merry K, Littlewood A, Gowen M. Expression of mRNA for IL-1β, IL-6 and TGF-β in developing human bone and cartilage. J Histochem Cytochem 1994;42:733-44.
19. Alderson MR, Tough TW, Ziegler SF, Grabstein KH. Interleukin 7 induces cytokine secretion and tumoricidal activity by human peripheral blood monocytes. J Exp Med 1991;173:923-30.
20. De Benedetti F, Massa M, Pignatti P, Kelley M, Faltynek CR, Martini A. Elevated circulating interleukin-7 levels in patients with systemic juvenile rheumatoid arthritis. J Rheumatol 1995;22:1581-5.
21. Komschlies KL, Grzegorzewski KJ, Wiltrout RH. Diverse immunological and hematological effects of interleukin-7: implications for clinical application. J Leukoc Biol 1995;58:623-33.
22. Takashima A, Matsue H, Bergstresser PR, Ariizumi K. Interleukin-7-dependent interaction of dendritic epidermal T cells with kerationcytes. J Invest Dermatol 1995;10 (Suppl 96):50-3.
23. Lotz M, Terkeltaub R, Villiger PM. Cartilage and joint inflammation. Regulation of IL-8 expression by human articular chondrocytes. J Immunol 1992;148:466-73.
24. Brunda MJ. Interleukin-12. J Leukoc Biol 1994;55:280-8.
25. Wolf SF, Sieburth D, Sypek J. Interleukin 12:A key modulator of immune function. Stem Cells 1994;12:154-68.
26. Trinchieri G, Wysocka M, D'Andrea A, Rengaraju M, Asre-Amezaga M, Kubin M, et al. Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation. Prog Growth Factor Res 1993;4:355-68.
27. Trembleau S, Germann T, Gately MK, Adorini L. The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol Today 1995;16:383-6.
28. Mattner F, Fischer S, Guckes S, Jin S, Kaulen H, Schmitt E, et al. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur J Immunol 1993;23:2202-8.
29. Bucht A, Larsson P, Weisbrot L, Thorne C, Pisa P, Smedegård G. et al. Expression of interferon-gamma (IFN-γ). IL-10. IL-12 and transforming growth factor-beta (TGF-β) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA). Clin Exp Immunol 1996;103:357-67.
30. Sugiyama E, Kuroda A, Taki H, Ikemoto M, Hori T. Yamashita N, et al. Interleukin-10 cooperates with interleukin-4 to suppress inflammatory cytokine production by freshly prepared adherent rheumatoid synovial cells. J Rheumatol 1995;22:2020-6.
31. van Roon JAG, van Roy JLAM, Gmelig-Meyling FHJ. Lafeber FPJG, Bijlsma WJ. Prevention and reversal cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum 1996;39:829-35.
32. Chomarat P, Banchereau J, Miossec P. Differential effects of interleukin 10 and 4 on the production of interleukin-6 by blood and synovium monocytes in rheumatoid arthritis. Arthritis Rheum 1995;38:1046-54.
33. Joosten LAB, Lubberts E, Durez P, Helsen MAM, Jacobs MJM, Goldman M, et al. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Arthritis Rheum 1997;40:249-60.
34. Cohen SBA, Katsikis PD, Chu CQ, Thomssen H, Webb LMC, Maini RN, et al. High levels of interleukin-10 production by the activated T cell population within the rheumatoid synovial membrane. Arthritis Rheum 1995;38:946-52.
35. Isomäki P, Luukkainen R, Saario R, Toivanen P, Punnonen J. Interleukin-10 functions as an anti-inflammatory cytokine in rheumatoid synovium. Arthritis Rheum 1996;39:386-95.
36. Shingu M, Miyauchi S, Nagai Y, Yasutakes C, Horie K. The role of IL-4 and IL-6 in IL-1-dependent cartilage matrix degradation. Br J Rheumatol 1995;34:101-6.
37. Cicuttini FM, Byron KA, Maher D, Wootton AM, Muirden KD, Hamilton JA. Serum IL-4, IL-10 and IL-6 levels in inflammatory arthritis. Rheumatol Int 1995;14:201-6.
38. Chu CQ, Field M, Allard S, Abney E, Feldmann M, Maini RN. Detection of cytokines at the cartilage pannus junction in patients with rheumatoid arthritis:Implications for the role of cytokines in cartilage destruction and repair. Br J Rheumatol 1992;31:653-61.
39. Mihara M, Moriya Y, Kishimoto T, Ohsugi Y. Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor. Br J Rheumatol 1995;34:321-5.
40. Pelletier JP, DiBattista JA, Roughley P, McCollum R, MartelPelletier J. Cytokines and inflammation in cartilage degradation. Rheum Dis Clin North Am 1993;19:545-68.